Analyze the earnings history of Travere Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | PM | TVTX | Q1 | -$0.82 | -$0.97 | — | — | $56.99M | $44.37M | — | — | Get Alert |
02/15/2024 | PM | TVTX | Q4 | -$0.76 | -$1.26 | -$0.94 | 25.40% | $55.87M | $41.51M | $45.06M | 8.55% | Get Alert |
11/07/2023 | PM | TVTX | Q3 | -$0.86 | — | $2.27 | — | $28.07M | — | $37.09M | — | Get Alert |
08/03/2023 | PM | TVTX | Q2 | -$0.65 | -$1.16 | -$0.77 | 33.62% | $54.17M | $53.93M | $59.70M | 10.69% | Get Alert |
05/04/2023 | PM | TVTX | Q1 | -$0.82 | -$1.17 | -$0.82 | 29.91% | $48.49M | $50.61M | $56.99M | 12.61% | Get Alert |
02/23/2023 | PM | TVTX | Q4 | -$0.61 | -$1.07 | -$0.76 | 28.97% | $57.25M | $53.01M | $55.87M | 5.39% | Get Alert |
10/27/2022 | PM | TVTX | Q3 | -$0.13 | -$0.89 | -$0.76 | 14.61% | $68.22M | $54.76M | $53.50M | -2.31% | Get Alert |
08/04/2022 | AM | TVTX | Q2 | -$0.39 | -$0.88 | -$0.65 | 26.14% | $54.62M | $49.63M | $54.17M | 9.14% | Get Alert |
05/05/2022 | PM | TVTX | Q1 | -$0.55 | -$0.85 | -$0.82 | 3.53% | $47.41M | $51.92M | $48.49M | -6.61% | Get Alert |
02/24/2022 | PM | TVTX | Q4 | -$0.48 | -$0.72 | -$0.61 | 15.28% | $50.98M | $57.81M | $57.25M | -0.97% | Get Alert |
10/28/2021 | PM | TVTX | Q3 | -$0.11 | -$0.54 | -$0.13 | 75.93% | $51.14M | $60.93M | $68.22M | 11.96% | Get Alert |
07/29/2021 | PM | TVTX | Q2 | -$0.22 | -$0.68 | -$0.39 | 42.65% | $48.43M | $50.33M | $54.62M | 8.52% | Get Alert |
05/06/2021 | PM | TVTX | Q1 | -$0.20 | -$0.39 | -$0.55 | -41.03% | $47.77M | $50.09M | $47.41M | -5.36% | Get Alert |
03/01/2021 | PM | TVTX | Q4 | -$0.70 | -$0.47 | -$0.48 | -2.13% | $46.69M | $51.66M | $50.98M | -1.31% | Get Alert |
11/05/2020 | PM | TVTX | Q3 | -$0.66 | -$0.51 | -$0.11 | 78.43% | $44.37M | $48.14M | $51.14M | 6.23% | Get Alert |
07/30/2020 | PM | TVTX | Q2 | -$0.58 | -$0.55 | -$0.22 | 60.00% | $44.71M | $47.08M | $48.43M | 2.87% | Get Alert |
05/11/2020 | PM | TVTX | Q1 | -$0.63 | -$0.67 | -$0.20 | 70.15% | $39.57M | $43.43M | $47.77M | 9.99% | Get Alert |
02/24/2020 | PM | TVTX | Q4 | -$0.21 | -$0.64 | -$0.70 | -9.38% | $43.77M | $46.02M | $46.69M | 1.45% | Get Alert |
10/30/2019 | PM | TVTX | Q3 | -$0.68 | -$1.05 | -$0.66 | 37.14% | $40.71M | $45.30M | $44.37M | -2.05% | Get Alert |
Travere Therapeutics (TVTX) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 15, 2024 for Q4.
The Actual EPS was $-0.94, which beat the estimate of $-1.26.
The Actual Revenue was $45.1M, which beat the estimate of $41.5M.
Browse earnings estimates, EPS, and revenue on all stocks.